Harbinger Research, LLC Issues Investment Report for Linkwell Corporation Amidst Bird Flu Concerns


NEW YORK, Oct. 19, 2005 (PRIMEZONE) -- Harbinger Research LLC, www.harbingerresearch.com, an independent research firm, issued an investment report today for Linkwell Corporation (OTCBB:LWLL), a leading developer, manufacturer and marketer of disinfectant healthcare products in the People's Republic of China.

The report provides an in-depth summary and overview of the Company as an investment opportunity, an overview of its businesses, and its sales and marketing strategy, including a historical industry background.

The report is available free of charge at http://www.harbingerresearch.com

About Harbinger Research, LLC:

Harbinger Research is a quality-leading independent research company that provides insightful, in-depth equity research coverage to smaller U.S. traded companies and the individuals and institutions that invest in them.

For further information on Harbinger Research, please visit www.harbingerresearch.com

About Linkwell Corporation

Linkwell Corporation is a leading developer, manufacturer, and marketing of disinfectant healthcare products in the People's Republic of China, through its 90% owned subsidiary Shanghai Likang Disinfectant High Tech Company (Likang). Linkwell Corporation is a U.S. corporation headquartered in Boca Raton, Florida, and is publicly traded in the OTC Bulletin Board Exchange under the symbol (OTCBB:LWLL).

Linkwell's disinfectant healthcare products are the leading and only nationally recognized domestic Chinese brand in this market segment. Linkwell products include disinfectant, liquid and tablet products, as well as disinfectant instruments, devices and materials. These may also include air disinfecting machines, hot press bags, disinfection swabs and disinfection tampons. Through Likang, Linkwell is the only domestic Chinese company that has a national marketing and sales presence throughout all 22 provinces, 5 autonomous regions, and 4 special municipalities of the People's Republic of China. All inventory and order fulfillment is carried out of a 21,500 square foot facility in Shanghai's Jiading district. The company's products have gradually made their way from medical disinfection to also include civil disinfection, industrial disinfection, and agricultural and livestock disinfection. For more info about the company please visit http://www.linkwell.us.

Statement under the Private Securities Litigation Reform Act:

With the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risk and uncertainties that may individually or mutually impact the matters herein described, including but not limited to the ability of the Company to increase revenues in the future due to the developing and unpredictable markets for its products, the ability to achieve a positive cash flow, the ability to obtain orders for or install its products, the ability to obtain new customers and the ability to continue to commercialize its products, which could cause actual results or revenues to differ materially from those contemplated by these statements.


            

Tags


Contact Data